loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 5440 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Chemtrade Solutions LLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Chemtrade Solutions LLC (1)

    filter

    01 POTASSIUM CHLORIDE (1)

    filter

    01 Canada (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    AURORIUM LLC

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      POTASSIUM CHLORIDE

      PDF Supplier PDF
      URL Supplier Web Content
      5440
      Active
      1984-06-29
      Complete
      2013-04-26
      2013-04-19
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 5440 of Aurorium Llc

      Looking for Drug Master Files (DMF) for 5440 of Aurorium Llc 1

      20

      Aurorium Llc, based in Canada, is a pharmaceutical company.

      One of their notable products is POTASSIUM CHLORIDE, with a corresponding US DMF Number 5440.

      Remarkably, this DMF maintains an Active status since its submission on June 29, 1984, highlighting commitment to regulatory compliance.

      Their GDUFA DMF Review was successfully complete, with a review date of April 26, 2013, and payment made on April 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

      Post Enquiry
      POST ENQUIRY